Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 29, 2026
WuXi Biologics and Sinorda Biomedicine announced a strategic collaboration for the development and manufacturing of SND006, a novel bispecific antibody, for the potential treatment of inflammatory bowel disease (IBD) and other autoimmune diseases.
read more
Thursday, January 29, 2026
Frontage Europe, a wholly owned subsidiary of Frontage Laboratories Inc., has relocated its bioanalytical laboratory to a new 2,500-square-meter facility near Milan, Italy.
read more
Thursday, January 29, 2026
Vetter has confirmed its plans to build a state-of-the-art production facility in the Saarland region of southwest Germany.
read more
Thursday, January 29, 2026
Alcami Corporation announced the promotion of Guy Kubi to Chief Operating Officer (COO), effective immediately.
read more
Tuesday, January 27, 2026
Eurofins CDMO Alphora announced the development and launch of a new AI-powered software for high throughput salt and co-crystal screening – now a core component of all solid-state screening programs.
read more
Tuesday, January 27, 2026
Astoriom has expanded its sample management capabilities in the US with the acquisition of Precision Stability Storage. This acquisition marks a strategic expansion of Astoriom’s footprint in North America, strengthening its presence in high-growth ...
read more
Tuesday, January 27, 2026
iXCells Biotechnologies and Rosebud Biosciences announced a partnership to develop a personalized, human-based approach for predicting drug safety and informing translational decision-making in rare diseases.
read more
Tuesday, January 27, 2026
Evestia Clinical announced the acquisition of ICRC-Weyer GmbH, a Berlin-based, long-established CRO and scientific consultancy. The acquisition strengthens Evestia Clinical's presence in Germany and Europe and further enhances the company's full-...
read more
Thursday, January 22, 2026
Rentschler Biopharma SE announced that Detra Glinatsis has rejoined the company as Head of Business Development U.S. In this newly created role, Ms. Glinatsis will lead all business development activities related to the U.S. market. She reports to Dr...
read more
Thursday, January 22, 2026
bioMérieux announced the acquisition of Accellix, a company specializing in rapid, automated flow cytometry solutions for cell and gene therapy quality control.
read more
Wednesday, January 21, 2026
Syngene International announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning ...
read more
Wednesday, January 21, 2026
Charles River Laboratories International and Gazi University Faculty of Medicine, announced a gene therapy contract development and manufacturing organization (CDMO) collaboration, providing plasmid DNA for AAV production and in vitro efficacy ...
read more
Tuesday, January 20, 2026
Crown Bioscience announced that its San Diego laboratory has achieved College of American Pathologists (CAP) accreditation. This milestone builds on the site’s Clinical Laboratory Improvement Amendments (CLIA) certification, obtained in July 2025, ...
read more
Tuesday, January 20, 2026
WuXi AppTec announced that it has been recognized on the "A List" for leadership in corporate transparency and performance across both Climate Change and Water Security by CDP (Carbon Disclosure Project). This recognition, which represents CDP's ...
read more
Tuesday, January 20, 2026
Alcami has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence in the Research Triangle region and supports the company's continued expansion of ...
read more